
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Koninklijke Philips NV ADR (PHG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: PHG (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $32.77
1 Year Target Price $32.77
1 | Strong Buy |
1 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 2.05% | Avg. Invested days 36 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 26.98B USD | Price to earnings Ratio 148.42 | 1Y Target Price 32.77 |
Price to earnings Ratio 148.42 | 1Y Target Price 32.77 | ||
Volume (30-day avg) 3 | Beta 0.83 | 52 Weeks Range 20.65 - 31.64 | Updated Date 09/15/2025 |
52 Weeks Range 20.65 - 31.64 | Updated Date 09/15/2025 | ||
Dividends yield (FY) 3.43% | Basic EPS (TTM) 0.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.91% | Operating Margin (TTM) 9.24% |
Management Effectiveness
Return on Assets (TTM) 2.37% | Return on Equity (TTM) 1.51% |
Valuation
Trailing PE 148.42 | Forward PE 14.79 | Enterprise Value 34559937570 | Price to Sales(TTM) 1.51 |
Enterprise Value 34559937570 | Price to Sales(TTM) 1.51 | ||
Enterprise Value to Revenue 1.65 | Enterprise Value to EBITDA 12.21 | Shares Outstanding 950574016 | Shares Floating 767446306 |
Shares Outstanding 950574016 | Shares Floating 767446306 | ||
Percent Insiders - | Percent Institutions 5.42 |
Upturn AI SWOT
Koninklijke Philips NV ADR

Company Overview
History and Background
Koninklijke Philips NV was founded in 1891 in Eindhoven, Netherlands. Initially focused on manufacturing light bulbs, Philips has evolved into a diversified technology company with interests in healthcare, personal health, and connected care. Key milestones include the introduction of the Philishave electric shaver in 1939, expansion into medical equipment in the 20th century, and a recent shift towards health technology solutions.
Core Business Areas
- Diagnosis & Treatment: Develops and markets medical imaging systems, image-guided therapy solutions, and healthcare informatics. Products include MRI, CT scanners, ultrasound systems, and interventional X-ray systems.
- Connected Care: Offers patient monitoring solutions, telehealth platforms, and hospital management systems designed to improve patient outcomes and efficiency. Includes products for sleep and respiratory care, and personal emergency response systems.
- Personal Health: Focuses on consumer health products, including oral healthcare, mother and child care, male grooming, and beauty devices. Main products are Sonicare electric toothbrushes and Avent baby products.
Leadership and Structure
The CEO of Koninklijke Philips NV is Roy Jakobs. The company operates with a divisional structure aligned with its core business areas. The board of directors oversees the executive management team.
Top Products and Market Share
Key Offerings
- Magnetic Resonance Imaging (MRI) Systems: Philips provides advanced MRI systems used for diagnostic imaging. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Canon Medical Systems. Market share varies by region but typically ranks among the top three globally. Revenue is a major portion of their diagnostic treatment revenue. Not possible to provide a specific number.
- Computed Tomography (CT) Scanners: Philips offers CT scanners used for a wide range of medical applications. Major competitors are GE Healthcare (GE), Siemens Healthineers (SIEGY), and Canon Medical Systems. Market share varies by region and modality; similar to MRI, usually in the top 3 in the world. Revenue is a major portion of their diagnostic treatment revenue. Not possible to provide a specific number.
- Sonicare Electric Toothbrushes: Philips Sonicare is a leading brand of electric toothbrushes focused on premium oral healthcare. Competitors include Oral-B (PG) and Colgate (CL). Sonicare has a significant market share in the electric toothbrush market.
- Patient Monitoring Systems: Philips offers a wide range of patient monitoring solutions used in hospitals and other healthcare settings. Competitors include Medtronic (MDT), Masimo (MASI) and GE Healthcare (GE). Philips holds a significant market share.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing growth due to aging populations, increasing prevalence of chronic diseases, and technological advancements. The personal health segment is driven by consumer interest in wellness and preventative care. Increasing regulation and cybersecurity threats are key concerns.
Positioning
Philips is positioning itself as a leader in health technology, emphasizing integrated solutions and data-driven insights. Its competitive advantages include a strong brand reputation, a broad product portfolio, and a global presence.
Total Addressable Market (TAM)
The global healthcare technology market is expected to reach hundreds of billions of dollars. Philips is well-positioned to capture a significant portion of this TAM through its diverse portfolio.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Diversified product portfolio
- Global presence
- Innovation in health technology
- Established distribution network
Weaknesses
- Past product recalls have damaged reputation
- Complex organizational structure
- Exposure to regulatory risks
- Dependence on healthcare spending
Opportunities
- Growth in emerging markets
- Expansion of telehealth services
- Increased adoption of AI and data analytics
- Strategic acquisitions
- Growing demand for personalized healthcare
Threats
- Intense competition
- Technological obsolescence
- Changes in healthcare regulations
- Economic downturns
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- GE
- SIEGY
- MDT
- PG
- CL
Competitive Landscape
Philips' faces competition from various players in its different business segments. Its advantages include a strong brand and a diversified portfolio. Disadvantages may include higher cost structure in some areas.
Major Acquisitions
Spectranetics
- Year: 2017
- Acquisition Price (USD millions): 2200
- Strategic Rationale: To expand Philips' image-guided therapy portfolio.
Growth Trajectory and Initiatives
Historical Growth: Philips' growth has been influenced by economic conditions, industry trends, and strategic decisions. Refer to Philips' financial reports for historical growth data.
Future Projections: Analyst projections for Philips' future growth are available from financial analysts. Please review analyst reports.
Recent Initiatives: Recent initiatives include expanding its presence in emerging markets, focusing on health technology solutions, and streamlining its business operations.
Summary
Koninklijke Philips NV is a large global conglomerate in the healthcare technology space with a strong brand presence. Its shift towards healthcare is promising, given the increasing demand for medical equipment and services. However, the company needs to address product recalls and operational efficiency. Competition remains a key challenge for Koninklijke Philips NV, as does the need to stay ahead of technological advancements and regulatory changes.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Financial News Outlets
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market data and financial figures are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Koninklijke Philips NV ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1987-12-30 | President, CEO & Chairman of the Board of Management Mr. Roy Jakobs | ||
Sector Healthcare | Industry Medical Devices | Full time employees 67263 | Website https://www.philips.com |
Full time employees 67263 | Website https://www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.